Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: A pharmacovigilance experience utilizing an ADR trigger tool

• DOI: 10.1016/j.jsps.2022.01.021
• Publication Date: 2022-01-29T23:51:35Z
• Authors: Bashayer Alshehail; Zainab Al Jamea; Royes Chacko; Fawaz Alotaibi; Nadia Ismail; Dhafer Alshayban
• Keywords: Pandemic; Coronavirus; Drug reaction; Adverse drug reaction; 2019-20 coronavirus outbreak

Since the World Health Organization declared coronavirus disease (COVID-19) as a pandemic, most countries started treating their patients with various therapies. However, data regarding safety and effectiveness is still lacking.